Supplier · Peer benchmark
Peer comparison
How UL Global Pharma stacks up against suppliers competing for the same workloads — based on overlap with its 1 signature CPV code over the last 24 months. Target HQ: North West.
Value band:
/
CohortUL Global Pharma(You)Dr Reddy's Laboratories (UK) LtdJanssen-Cilag LtdAbbVie LtdThornton and Ross LtdACCORD-UK LTD
iAuto-picked from 1 signature CPV code · last 24 months overlap
Metric | UG UL Global Pharma (You) · target supplier | DR Dr Reddy's Laboratories (UK) Ltd Peer · rank #2 | JA Janssen-Cilag Ltd Peer · rank #3 | AB AbbVie Ltd Peer · rank #4 | TA Thornton and Ross Ltd Peer · rank #5 | AC ACCORD-UK LTD Peer · rank #6 |
|---|---|---|---|---|---|---|
01ActivityVolume, scale, freshness | ||||||
| 12-month contractedAward value, last 12m | — | — | — | — | — | — |
| Framework headroomPer-supplier share of framework ceilings | — | — | — | — | — | — |
| Total awarded (lifetime)All time, all contracts | £52.6m(−82%) | £207.7m | £457.1m | £461.1m | £230.1m | £287.4m |
| Contracts won (12m)Distinct awards last year | — | 6 | 2 | 3 | 2 | |
How to read a target cell
The target column carries a delta — value compared to the peer median for that row. Direction-of-good varies by metric, so deltas are neutral.
Peer cell£499m(peer median £255m)
→
Target cell£11.7m(−97% vs median)
Money:
£N.Nm, £Nk, £N.NbnPercent: 42% · pp delta: (+12pp)Day delta: (−149 days) · missing: —